A Trisubstituted Benzimidazole Cell Division Inhibitor with Efficacy against Mycobacterium tuberculosis

• Susan E. Knudson,

  Affiliation Mycobacteria Research Laboratories, Department Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America

  ⨯
• Divya Awasthi,

  Affiliation Department of Chemistry, Stony Brook University, Stony Brook, New York, United States of America

  ⨯
• Kunal Kumar,

  Affiliation Institute of Chemical Biology & Drug Discovery, Stony Brook University, Stony Brook, New York, United States of America

  ⨯
• Alexandra Carreau,

  Affiliation Infectious Disease Therapeutic Strategic Unit, Sanofi-Aventis R&D, Toulouse, France

  ⨯
• Laurent Goullieux,

  Affiliation Infectious Disease Therapeutic Strategic Unit, Sanofi-Aventis R&D, Toulouse, France

  ⨯
• Sophie Lagrange,

  Affiliation Infectious Disease Therapeutic Strategic Unit, Sanofi-Aventis R&D, Toulouse, France

  ⨯
• Hélèn Vermet,

  Affiliation Infectious Disease Therapeutic Strategic Unit, Sanofi-Aventis R&D, Montpellier, France

  ⨯
• Iwao Ojima,

  Affiliations Department of Chemistry, Stony Brook University, Stony Brook, New York, United States of America, Institute of Chemical Biology & Drug Discovery, Stony Brook University, Stony Brook, New York, United States of America

  ⨯
• Richard A. Slayden

  * E-mail: richard.slayden@ColoState.edu

  Affiliation Mycobacteria Research Laboratories, Department Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America

  ⨯